Clinical Trial: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1203 in Advanced Solid Tumors.

U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876609) titled 'A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1203 in Advanced Solid Tumors.' on Oct. 09.

Brief Summary: This is an open label Phase 1, First in Human trial designed to evaluate the safety, tolerability pharmacokinetics, preliminary efficacy of BA1203 in participants with advanced solid tumors.

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: BA1203

intravenous (IV) once every 2 weeks (Q2W).

Recruitment Status: RECRUITING

Sponsor: Shandong Boan Biotechnology Co., Ltd

Disclaimer: Curated by HT Syndication....